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Özet
Charcot-Marie-Tooth (CMT) hastalığı hem genetik hem de klinik 
olarak  oldukça  heterojen bir hastalıktır. Tanı için klinik ve elek-
trofizyolojik veriler esastır. CMT li çocuklar erken yaştan itibaren 
edinilmiş ayak zayıflığı, kontraktür ve deformiteler (pes kavus ve 
çekiç  parmaklar)  geliştirebilirler. CMT  de ayak ve  ayak bileğini 
hedef  alan  erken  girişimler  uzun  dönem  özürlülüğü  önleyebilir. 
Burada biz sonradan edinilmiş pes kavuslu ve çekiç parmaklı bir 
CMT hastasını sunmakta ve kısaca CMT nin tanısı, tedavisi ve re-
habilitasyonu için literatür taraması yapmaktayız. Sonuç olarak biz 
sonradan edinilmiş pes kavus ve çekiç parmağın ayırıcı tanısında 
CMT nin de akla gelmesi kanısındayız.
Anahtar Kelimeler
Pes Kavus, Çekiç Parmak, Charcot Marie Tooth Hastalığı.
Abstract
Charcot-Marie-Tooth (CMT) is a disease that is highly heteroge-
neous, both clinically and genetically. Clinical and electrophysiologi-
cal data are essential for diagnosis. Children with CMT experience 
acquired foot weakness, contracture and deformity (pes cavus and 
hammer toes) from an early age. Early intervention targeting the 
foot and ankle may prevent long-term disability in CMT. Here we 
present a CMT patient with acquired pes cavus and hammer toes 
and review the literature briefly for diagnosis, treatment, and re-
habilitation of CMT. As a result we conclude that CMT should also 
come into mind in the differential diagnosis of acquired pes cavus 
and hammer toes. 
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Introduction
The  hereditary  motor  and  sensory  neuropathies  (HMSN)  also 
called Charcot-Marie-Tooth disease (CMT)  describe a spectrum of 
slowly progressive inherited disorders affecting peripheral motor 
and sensory nerves. The underlying pathophysiology is a specific 
mutation in one of several myelin genes that results in compromise 
of the myelin integrity [1]. It is classified according to clinical fea-
tures, genetic inheritance, and electrophysiological and histopatho-
logical findings. The Dyck classification developed in the 1970s 
subdivided the HMSN (CMT) into types 1 through 7 based upon 
the clinical and electrophysiologic features [2]. The prevalence of 
CMT ranges from a rate of 8–41 per 100,000 people depending on 
the geographical region of origin [3].  The most common subtypes 
are CMT1 (demyelinating with autosomal dominant transmission) 
and CMT2 (axonal and usually dominant). CMT1A is the most 
common subgroup which results from the duplication of a genomic 
fragment that encompasses the PMP22 gene on chromosome 17 
[4]. CMT1A affects 60 to 80% of the general CMT population [5]. 
The wide range of foot/ankle manifestations in CMT1A compli-
cates the assessment, diagnosis and therapy. Children with CMT1A 
experience foot weakness, contracture and deformity, pes cavus 
from an early age [6]. The disease is characterized by weakness and 
atrophy of the distal muscle groups of the limbs, gait disturbance, 
impaired sensation in the hands and feet, decreased and/or absent 
deep tendon reflexes, and skeletal deformities such as pes cavus and 
hammer toes. Sensory loss of all modalities is seen [7]. Pes cavus 
is thought to be an almost universal manifestation of CMT1A, par-
ticularly in older children and adults [6,8]. In previous studies, pes 
cavus was apparent in early childhood in only 11-33 % of cases, but 
it increased to 62.5-80% during adolescence [7,9]. Foot and ankle 
muscle imbalance, reduced strength in all muscles of feet, intrinsic 
foot weakness, restriction of ankle dorsiflexion flexibility during 
weight-bearing which is a reflection of Achilles tendon shortening 
or osseous block in the ankle motrise are the pathogenetic mecha-
nisms of pes cavus in CMT1A (6). Charcot-Marie-Tooth disease 
should be suspected if a patient has cavus foot and distal symmetric 
atrophy. Orthotic treatment of the feet can improve the quality of 
life of patients with CMT by increasing their stability and confi-
dence when walking [10].
Here we present a CMT patient with pes cavus and hammer toes 
who had been undiagnosed formerly by his medical practitioner 
and a neurosurgeon. 
Case Report
A 16-year-old male was admitted to Physical Medicine and Reha-
bilitation department  in November 2009 with the complaint of pro-
gressive gait disturbance and leg weakness and drop left hand for 
3 years. At 11 years of age he presented with progressive tingling 
in his fingers and toes, diminished left hand strength, and difficulty 
climbing stairs. He had been admitted to a neurosurgery clinic in 
another centre 4 months ago but any diagnosis had not been yield. 
Examination  revealed  bilateral  pes  cavus,  hammer  toes  (Figure 
1a, 1b) and poor grip strength, with thinning of the left hand and 
distal forearm musculature. He had reduced strength in the lower 
extremities, atrophy of the intrinsic left hand muscles, decreased 
deep tendon reflexes in the lower extremities, and difficulty walk-
ing on his heels. Sensation was diminished in the left hand and 
feet to temperature, pinprick, and vibration. Tone was normal in 
the upper extremities but was increased at the ankles. He had dif-
ficulty maintaining balance. Upon neurological examination, there 
was mild weakness (4/5) in knee flexion and extension, and ankle 
dorsoflexion and planter flexion were 3/5, and left hand dorsiflexion 
was 1/5. Atrophy was noted in intrensic feet, left hand  and peroneal 
muscle groups. Nerve conduction velocity measurements disclosed 
marked slowing in both the left radial and left median and the bilat-
eral tibial nerves. The left radial sensory, left median sensory, left 
ulnar sensory, and bilateral sural sensory latencies were prolonged, 
with decreased amplitudes (demyelinating form with low NCVs.). 
Investigation with electromyography revealed minimal voluntary 
activity in the foot intrensec muscles bilaterally and left hand mus-
cles. There was no evidence of conduction block. We diagnosed the 
patient as HSMN (CMT) according to the clinical and electrophysi-
ological findings.
Discussion 
The pes cavus foot appears in childhood as a complex deformity. 
While the etiology may occasionally be idiopathic, its appearance 
is often the initial manifestation of a progressive neuromuscular 
disorder. The deformity presents significant difficulties both the pa-
tient and the physiotherapy stuff. The symptomatic pes cavus foot 
can be disabling. The deformity and the pain worsen with time. 
There are three broad etiologic categories resulting in a pes ca-
vus deformity [11]. The congenital pes cavus category (includes 
the arthrogrypotic foot, the residua of talipes, equinovarus and the 
idiopathic cavovarus). Posttraumatic pes cavus category that are 
partially neuromuscular in origin (compartment syndrome or crush 
injury) and partially structural in origin (fracture malunion or burn 
contracture). This group is uncommon and difficult to reconstruct. 
The neuromuscular pes cavus category include poliomyelitis, ce-
rebral palsy, spinal dysraphism, and degenerative diseases of the 
nervous system such as CMT disease is the most common, it is 
also the most important, since many cases of pes cavus deformi-
ty represent the early signs of a progressive CMT disease. CMT 
disease encompasses a group of clinically and genetically hetero-
geneous peripheral neuropathies. This disease affects males more 
than females by a 5.1:3 ratio [12]. The most commonly used CMT 
classification combines clinical findings  with the pattern of  in-
heritance (autosomal dominant, autosomal recesive, or X-linked) 
and the electrophysiological findings or those from pathological 
anatomy (demyelination or axonal degeneration). There are 7 main 
categories of CMT. Most cases can be included in type CMT 1A 
(demyelinating forms, with low conduction velocities and auto-
somal dominant transmission) characterized by progressive foot 
and ankle weakness, contractures and pes cavus deformity [6,7]. 
Patients may have diminished deep tendon reflexes, dysphasia and 
French nerve involvement [13]. There is also a reported 10 percent 
incidence of scoliosis [14]. The characteristic changes seen in the 
upper extremities are intrinsic atrophy of the hands and weakness 
of the radially innervated muscle of the forearms. The foot often has 
cavus deformities and claw toes. Also, the forefoot has a tendency 
to be adducted and the heel to be in varus [15]. Since the first and 
most severely affected function in all cases is ambulation, orthoses 
are essential [16]. Orthotic treatment of the feet can improve the 
(b)
Figure 1. (a) Pes cavus of the CMT patient (b) Pes cavus and ham-
mer toes of the CMT patient.
(a)
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quality of life of patients with CMT by increasing their stability and 
confidence when walking. In the large majority of patients there is 
no severe weakness in the quadriceps and the glutei muscles, and 
ambulation is preserved for the whole life even though special foot-
wear and orthotics are necessary to correct footdrop, foot rotation 
and plantarflexor failure, which are the major problems in CMT1A 
[17]. A specific design should be made for each patient, in accor-
dance with the morphology and functionality of the foot. However, 
foot orthoses for patients with CMT should always include a rocker 
sole in their design. This component should cover the entire fore-
foot. It should be wide and not very thick [10]. Rotation and walk-
ing is corrected by wedges under the foot orthoses and the sole of 
the shoe with a bit of heel [18]. Surgery is essential for severe foot 
deformities in CMT.
Exercise intolerance and undue fatigue are common complaints 
in patients with Charcot–Marie–Tooth (CMT) disease [19]. Con-
ventional  rehabilitation  programs  with  interval-training  exercise 
(ITE) improves  cardiorespiratory capacities, isokinetic concentric 
strength, functional ability measurements, fatigue and pain during 
training in CMT patients [19]. At present, there is no etiological 
medical treatment in CMT. High dose Ascorbic acid may repress 
PMP22 gene expression by acting on intracellular cyclic adenosine 
monophosphate levels and adenylate cyclase activity  and induce 
remyelination and improve locomotor functioning in CMT1A pa-
tients [20].
As a result we conclude that CMT should come into mind in the 
differential diagnosis of pes cavus and hammer toes. 
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